H. Schuldes et al., LOSS OF IN-VITRO CYTOTOXICITY OF CISPLATIN AFTER STORAGE AS STOCK SOLUTION IN CELL-CULTURE MEDIUM AT VARIOUS TEMPERATURES, Cancer, 79(9), 1997, pp. 1723-1728
BACKGROUND. Cisplatin (cis-dichlorodiammineplatinum [II]) is one of th
e most potent and widely used cytotoxic drugs in cancer therapy. Howev
er, in vitro cytotoxicity assays often yield diverging results. Theref
ore, it is believed by many investigators that cisplatin is not effect
ive in vitro. The authors investigated whether the experimental condit
ions used could be responsible for the diverging results. METHODS, In
vitro cytotoxicity assays were performed using the original cisplatin
solution as distributed by the manufacturer or a 5-fold dilution of th
is in cell culture medium after storage for 2 weeks or 1 month at Vari
ous temperatures (room temperature, 4 degrees C, and -20 degrees C). R
ESULTS. The original solution of cisplatin retained the full cytotoxic
potency for at least 1 month under all storage conditions tested. The
highest loss of cytotoxicity resulted from storage of cisplatin in ce
ll culture medium in which a >7-fold increase in the concentration tha
t inhibits 50% occurred after 2 weeks' storage at room temperature. So
lutions stored in culture medium at -20 degrees C retained full cytoto
xic potency. CONCLUSIONS, Cisplatin is a potent cytotoxic drug in vitr
o when stored under appropriate conditions. These findings are of rele
vance for in vitro studies with cisplatin. (C) 1997 American Cancer So
ciety.